bioMérieux S.A. logo

bioMérieux S.A.

BMXXY | OTC
Chart Builder DCF Calculator
$10.19
+$0.21 (+2.10%)
At close: Oct 15, 2026, 2:40 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Cash & Equivalents
569.8M 449.8M 352.4M 552.6M 803.5M 389.2M
Short-Term Investments
n/a n/a n/a n/a n/a n/a
Long-Term Investments
129.4M 180.2M 220.2M 91M 62M 50.6M
Other Long-Term Assets
10.3M 24.8M 7.7M -799.7M -648.9M -615.1M
Receivables
948.2M 857.6M 865.5M 865.2M 709M 689.5M
Inventory
975.2M 1.04B 908.5M 767.5M 648.2M 562.2M
Other Current Assets
n/a 92.3M 78.8M -30.3M -28.2M -20.3M
Total Current Assets
2.54B 2.5B 2.21B 2.22B 2.18B 1.66B
Property-Plant & Equipment
1.66B 1.7B 1.51B 1.37B 1.22B 1.07B
Goodwill & Intangibles
1.13B 1.22B 1.23B 2.25B 1.75B 1.69B
Total Long-Term Assets
3.03B 3.27B 3.05B 2.97B 2.42B 2.27B
Total Assets
5.57B 5.77B 5.26B 5.19B 4.61B 3.93B
Account Payables
262.1M 272.4M 265.1M 269.4M 239.5M 207.1M
Deferred Revenue
77.9M n/a 80.1M 88.5M 84M 68.7M
Short-Term Debt
99.3M 111.6M 136M 160.8M 74.9M 104.5M
Other Current Liabilities
575M 234.5M 525.9M 537.2M 549.2M 474.8M
Total Current Liabilities
1.06B 1.13B 1.09B 1.13B 955.8M 923.8M
Long-Term Debt
211.3M 207.1M 234.1M 224.7M 265.2M 249.2M
Other Long-Term Liabilities
48M 49.2M 53.3M 41.2M 62.5M 64.5M
Total Long-Term Liabilities
404M 424.1M 419.7M 412.6M 485.6M 522.7M
Total Liabilities
1.47B 1.56B 1.51B 1.54B 1.44B 1.45B
Total Debt
461.4M 490.7M 518.8M 505.4M 462.5M 481.3M
Book Value
4.11B 4.21B 3.75B 3.64B 3.16B 2.48B
Book Value Per Share
34.50 35.47 31.58 30.76 26.61 20.91
Common Stock
12M 12M 12M 12M 12M 12M
Retained Earnings
397.5M 432.2M 357.6M 452.4M 601.1M 404.4M
Comprehensive Income
n/a n/a n/a 3.55B 3.05B 2.38B
Shareholders Equity
4.1B 4.2B 3.75B 3.6B 3.11B 2.43B
Total Investments
129.4M 180.2M 220.2M 91M 62M 50.6M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.